Home/Filings/4/0001127602-25-004537
4//SEC Filing

van der Vaart Sandra D 4

Accession 0001127602-25-004537

CIK 0000920148other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 11:31 AM ET

Size

13.3 KB

Accession

0001127602-25-004537

Insider Transaction Report

Form 4
Period: 2025-02-11
van der Vaart Sandra D
EVP, Chief Legal Officer
Transactions
  • Award

    Non-qualified Stock Options

    2025-02-11+3,4003,400 total
    Exercise: $245.14From: 2026-02-11Exp: 2035-02-10Common Stock (3,400 underlying)
  • Award

    Restricted Stock Unit

    2025-02-11+1,1302,580 total
    Common Stock (1,130 underlying)
  • Tax Payment

    Common Stock

    2025-02-11$245.14/sh86$21,0823,484.54 total
  • Exercise/Conversion

    Common Stock

    2025-02-11+3233,570.54 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-113232,257 total
    Common Stock (323 underlying)
Footnotes (7)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  • [F2]Stock withholding to satisfy tax withholding obligations.
  • [F3]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
  • [F4]The option vests in three equal annual installments beginning on the date reflected in this column.
  • [F5]The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
  • [F6]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
  • [F7]The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.

Issuer

LABCORP HOLDINGS INC.

CIK 0000920148

Entity typeother

Related Parties

1
  • filerCIK 0001537208

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 11:31 AM ET
Size
13.3 KB